Amicogen, Inc. (KOSDAQ:092040)
South Korea
· Delayed Price · Currency is KRW 2,570.00
+55.00 (2.19%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
| Raw Pharmaceutical Products | 122.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Raw Pharmaceutical Products Growth | 1.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Special Enzymes, Bio-new Materials, Bio-medical Materials, Health and Beauty | 54.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Special Enzymes, Bio-new Materials, Bio-medical Materials, Health and Beauty Growth | -0.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -3.43B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | -77.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Treatment of Incurable and Rare Diseases | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Treatment of Incurable and Rare Diseases Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
| Overseas | 146.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | 10.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 26.64B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -1.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|